DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Betoptic (Betaxolol Hydrochloride Ophthalmic) - Indications and Dosage

 
 



INDICATIONS AND USAGE

BETOPTIC Ophthalmic Solution has been shown to be effective in lowering intraocular pressure and is indicated in the treatment of ocular hypertension and chronic open-angle glaucoma. It may be used alone or in combination with other anti-glaucoma drugs.

In clinical studies BETOPTIC was safely used to lower intraocular pressure in 47 patients with both glaucoma and reactive airway disease who were followed for a mean period of 15 months. However, caution should be used in treating patients with severe reactive airway disease or a history of asthma.

DOSAGE AND ADMINISTRATION

The recommended dose is one to two drops of BETOPTIC Ophthalmic Solution in the affected eye(s) twice daily. In some patients, the intraocular pressure lowering responses to BETOPTIC Ophthalmic Solution may require a few weeks to stabilize. As with any new medication, careful monitoring of patients is advised.

If the intraocular pressure of the patient is not adequately controlled on this regimen, concomitant therapy with pilocarpine and other miotics, and/or epinephrine and/or carbonic anhydrase inhibitors can be instituted.

HOW SUPPLIED

BETOPTIC Ophthalmic Solution is a sterile, isotonic, aqueous solution of betaxolol hydrochloride. Supplied as follows: 2.5, 5, 10 and 15 mL in plastic ophthalmic DROP-TAINER® dispensers.

2.5 mL: NDC 0065-0245-20   10 mL: NDC 0065-0245-10

5 mL: NDC 0065-0245-05   15 mL: NDC 0065-0245-15

STORAGE

Store at room temperature

Rx Only

U.S. Patents Nos. 4,252,984; 4,311,708; 4,342,783

ALCON®

OPHTHALMIC

ALCON LABORATORIES, INC

Fort Worth, Texas 76134 USA

Printed in USA

236015-0598

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017